Markers for Ovarian Cancer May Show Up Years Earlier
TUESDAY, Jan. 5 (HealthDay News) — Concentrations of several biomarkers begin to grow three years before women are diagnosed with ovarian cancer, but only reach substantial elevation levels over the 12 months before diagnosis, new research finds.
Read more on HealthDay via Yahoo! News
Terramed Alliance News Nearly half of all breast cancer patients experienced chronic pain two to three years after treatment and more than half felt discomfort, according to a study by Danish researchers published Tuesday in the Journal of the American Medical Association, the New York Times reports. The study found that women younger than age 40, those who underwent radiation treatment and those who had surgery to remove lymph nodes in the armpit are most likely to experience lingering pain.
Research studies concerning resveratrol and prostate cancer have been promising. Researchers believe the results warrant future investigations concerning resveratrol prostate cancer prevention and treatment.
The antioxidant appears to inhibit the growth of cancerous cells, according to studies sponsored by the National Institute of Health in the United States. In later studies concerning resveratrol and prostate cancer, researchers included other phytochemicals, which are plant components with activity similar to, but different from, those of resveratrol.
Some phytochemicals inhibit the grown of cancerous cells while others cause them to commit suicide. Living cells are amazing things. You really wouldn’t believe everything that’s going on within them every minute of every day.
» Read more: Does Resveratrol Prevent Prostate Cancer?